Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:activities |
RNA interference
|
| gptkbp:appointed_by |
injection
|
| gptkbp:developed_by |
gptkb:Alnylam_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALX-0171
|
| gptkbp:is_tested_for |
clinical trials
|
| gptkbp:is_used_for |
treatment of diseases
|
| gptkbp:related_to |
genetic disorders
|
| gptkbp:status |
investigational drug
|
| gptkbp:targets |
gptkb:CEO
|
| gptkbp:year_created |
gptkb:2020
|
| gptkbp:bfsParent |
gptkb:Ablynx
|
| gptkbp:bfsLayer |
4
|